Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 26th in Philadelphia, Pennsylvania. Kevin Blyth, MD, from University of Glasgow
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 25th in Philadelphia, Pennsylvania. This panel includes Dawn Besserman, Esq. from
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 25th in Philadelphia, Pennsylvania. This panel includes Melina Marmarelis, MD from
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 25th in Philadelphia, Pennsylvania. Carly Roop, RD, CSO, MA, LDN, from
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 25th in Philadelphia, Pennsylvania. Santhosshi Narayanan, MD, FACP from MD Anderson
The Mesothelioma Applied Research Foundation announced its latest research grant recipients, awarding a total of $300,000 at the International Symposium on Malignant Mesothelioma in Philadelphia
Many of our MesoTV episodes and other educational materials discuss the patient: their stories, their emotions, the science behind their diagnosis. This episode is solely
Vivace Therapeutics, a company that develops cancer treatments, announced on July 30, 2025, that the U.S. Food and Drug Administration (FDA) has granted its experimental